
NEJM Interview: Peter Ubel on strategies for protecting patients from high out-of-pocket costs for drugs with questionable benefits.
NEJM Interviews
00:00
Exploring Policies for Drug Price Regulation and Patient Cost Relief
This chapter examines potential federal policy measures to regulate new drug prices, emphasizing cost-effectiveness analysis akin to UK's system. It discusses Medicare's role in setting price thresholds and the bipartisan effort to tackle high medication costs impacting Americans.
Transcript
Play full episode